Lemonade, Inc.|4Dec 10, 5:56 PM ET

Eckstein Adina 4

4 · Lemonade, Inc. · Filed Dec 10, 2025

Form 4

Period: 2025-12-08

Chief Operating Officer

Transactions

Exercise/Conversion
COMMON STOCK
2025-12-08$24.47/sh+16,250$397,638→ 244,237 total
Exercise/Conversion
COMMON STOCK
2025-12-08$44.57/sh+1,549$69,039→ 245,786 total
Sale
COMMON STOCK
2025-12-08$78.97/sh−17,799$1,405,587→ 227,987 total
Sale
COMMON STOCK
2025-12-08$78.92/sh−15,839$1,250,014→ 212,148 total
Sale
COMMON STOCK
2025-12-08$78.94/sh−7,919$625,126→ 204,229 total
Exercise/Conversion
COMMON STOCK
2025-12-09$44.57/sh+29,237$1,303,093→ 233,466 total
Sale
COMMON STOCK
2025-12-09$77.17/sh−29,237$2,256,219→ 204,229 total
Exercise/Conversion
STOCK OPTION
2025-12-08$24.47/sh−16,250$397,638→ 0 total
Exercise: $24.47Exp: 2030-06-06→ COMMON STOCK (16,250 underlying)
Exercise/Conversion
STOCK OPTION
2025-12-08$44.57/sh−1,549$69,039→ 33,751 total
Exercise: $44.57Exp: 2031-12-06→ COMMON STOCK (1,549 underlying)
Exercise/Conversion
STOCK OPTION
2025-12-09$44.57/sh−29,237$1,303,093→ 4,514 total
Exercise: $44.57Exp: 2031-12-06→ COMMON STOCK (29,237 underlying)

Footnotes (3)

[F1]Represents sale pursuant to a Rule 10b5-1 trading plan, adopted September 8, 2025.
[F2]This stock option is fully vested.
[F3]The option began vesting and became exercisable in 16 equal quarterly installments beginning on March 6, 2022.

Documents

1 file